23.85
+1.70
+(7.67%)
As of 8:03:30 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | 1.78B | 1.99B | 7.53B | 7.98B |
| Low Estimate | 1.7B | 1.91B | 7.19B | 7.42B |
| High Estimate | 1.86B | 2.12B | 7.99B | 8.52B |
| Year Ago Sales | 1.8B | 1.94B | 7.12B | 7.53B |
| Sales Growth (year/est) | -0.84% | 2.54% | 5.74% | 6.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| WHC.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Initiated | JP Morgan: Overweight | 4/8/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/3/2025 |
| Maintains | Citigroup: Buy to Buy | 1/15/2025 |
| Upgrade | CIBC: Neutral to Outperformer | 1/15/2025 |
| Maintains | Truist Securities: Hold to Hold | 1/6/2025 |
| Upgrade | Raymond James: Market Perform to Outperform | 12/23/2024 |